Lutz-Miescher Disease

Lutze-Mischer disease is a rare skin disease that appears as red spots on the skin accompanied by itching and burning. The disease was discovered in 1950 by the French doctor Lutz and the Swiss dermatologist Miescher.

Symptoms of Luce Mischer disease can vary and depend on the form of the disease. The most common symptoms are:

1. Red spots on the skin that can come in different sizes and shapes.
2. Itching and burning of the skin.
3. Redness of the eyes and nose.
4. Increased body temperature.
5. Weakness and fatigue.
6. Decreased appetite.

The cause of Luce Mischer disease is still unknown, but it is believed that it may be related to a compromised immune system and allergic reactions.

Treatment for Luce Mischer disease may vary, depending on the form of the disease and its severity. Antihistamines, corticosteroids, and other medications are usually prescribed to help relieve symptoms. Treatments aimed at strengthening the immune system may also be used.

Luce mischer disease is a rare disease that can lead to serious health consequences. Therefore, it is important to consult a doctor promptly and begin treatment to avoid complications.

Lutz-Miescher disease (angioedema, angioneurotic tumor; synonym angioedema) is an acute disease from the group of angioedema, characterized by the spread of edema of the skin, subcutaneous tissue, and sometimes mucous membranes and underlying tissues under the influence of neurogenic factors; the general condition of the patient remains normal or very slightly disturbed. It is usually observed in children 2–15 years of age and in adults, sometimes the development of relapses and/or repeated attacks is possible.

Treatment: hospitalization for severe disease is not indicated. For treatment, cold application to the affected area is recommended. Treatment is carried out at home until the symptoms disappear: restriction of physical activity, exclusion of hot baths, baths, saunas, prolonged exposure to the sun; Raw plant and dairy foods should be consumed sparingly. It is preferable to continue taking aspirin or suprastin, the course of treatment of which is usually 2 weeks or more. The prognosis is usually favorable. Does not leave a scar. With frequent relapses, surgical therapy may be necessary.

When choosing a treatment method, it is necessary to take into account the patient’s age and the presence of other chronic diseases, including those that can provoke an attack of angioedema.